The role of genetic and epigenetic GNAS alterations in the development of early-onset obesity

Alaa Abbas; Ayat S Hammad; Mashael Al-Shafai

doi:10.1016/j.mrrev.2023.108487

The role of genetic and epigenetic GNAS alterations in the development of early-onset obesity

Mutat Res Rev Mutat Res. 2023 Dec 14:793:108487. doi: 10.1016/j.mrrev.2023.108487. Online ahead of print.

Authors

Alaa Abbas¹, Ayat S Hammad², Mashael Al-Shafai³

Affiliations

¹ Department of Biomedical Sciences, College of Health Sciences, QU Health, Qatar University, P.O. Box 2713, Doha, Qatar.
² Department of Biomedical Sciences, College of Health Sciences, QU Health, Qatar University, P.O. Box 2713, Doha, Qatar; Biomedical Research Center, Qatar University, P.O. Box 2713, Doha, Qatar.
³ Department of Biomedical Sciences, College of Health Sciences, QU Health, Qatar University, P.O. Box 2713, Doha, Qatar; Biomedical Research Center, Qatar University, P.O. Box 2713, Doha, Qatar. Electronic address: malshafai@qu.edu.qa.

PMID: 38103632
DOI: 10.1016/j.mrrev.2023.108487

Abstract

Background: GNAS (guanine nucleotide-binding protein, alpha stimulating) is an imprinted gene that encodes G_sα, the α subunit of the heterotrimeric stimulatory G protein. This subunit mediates the signalling of a diverse array of G protein-coupled receptors (GPCRs), including the melanocortin 4 receptor (MC4R) that serves a pivotal role in regulating food intake, energy homoeostasis, and body weight. Genetic or epigenetic alterations in GNAS are known to cause pseudohypoparathyroidism in its different subtypes and have been recently associated with isolated, early-onset, severe obesity. Given the diverse biological functions that G_sα serves, multiple molecular mechanisms involving various GPCRs, such as MC4R, β₂- and β₃-adrenoceptors, and corticotropin-releasing hormone receptor, have been implicated in the pathophysiology of severe, early-onset obesity that results from genetic or epigenetic GNAS changes.

Scope of review: This review examines the structure and function of GNAS and provides an overview of the disorders that are caused by defects in this gene and may feature early-onset obesity. Moreover, it elucidates the potential molecular mechanisms underlying G_sα deficiency-induced early-onset obesity, highlighting some of their implications for the diagnosis, management, and treatment of this complex condition.

Major conclusions: G_sα deficiency is an underappreciated cause of early-onset, severe obesity. Therefore, screening children with unexplained, severe obesity for GNAS defects is recommended, to enhance the molecular diagnosis and management of this condition.

Keywords: Early-onset obesity; Methylation defects; Molecular mechanisms; Mutations; Stimulatory G protein alpha subunit.

Publication types

Review